Bank of America
BNTX icon

Bank of America’s BioNTech BNTX Stock Holding History

Bank of America’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.2M Sell
486,205
-416,824
-46% -$39.2M ﹤0.01% 1794
2026
Q1 		$80.3M Buy
903,029
+166,432
+23% +$17.1M 0.01% 1276
2025
Q4 		$70.1M Buy
736,597
+163,241
+28% +$16.4M 0.01% 1326
2025
Q3 		$56.5M Buy
573,356
+444,332
+344% +$47.5M ﹤0.01% 1641
2025
Q2 		$13.7M Sell
129,024
-164,752
-56% -$16.6M ﹤0.01% 2926
2025
Q1 		$26.8M Buy
293,776
+219,325
+295% +$24.6M ﹤0.01% 2150
2024
Q4 		$8.48M Sell
74,451
-139,203
-65% -$15.9M ﹤0.01% 3112
2024
Q3 		$25.4M Buy
213,654
+121,666
+132% +$11.2M ﹤0.01% 2177
2024
Q2 		$7.39M Sell
91,988
-115,643
-56% -$10.6M ﹤0.01% 3248
2024
Q1 		$19.2M Buy
207,631
+65,947
+47% +$6.32M ﹤0.01% 2332
2023
Q4 		$15M Buy
141,684
+39,116
+38% +$3.94M ﹤0.01% 2441
2023
Q3 		$11.1M Sell
102,568
-25,887
-20% -$2.86M ﹤0.01% 2617
2023
Q2 		$13.9M Sell
128,455
-15,988
-11% -$1.8M ﹤0.01% 2379
2023
Q1 		$18M Buy
144,443
+42,234
+41% +$5.8M ﹤0.01% 2226
2022
Q4 		$15.4M Buy
102,209
+8,522
+9% +$1.31M ﹤0.01% 2247
2022
Q3 		$12.6M Buy
93,687
+22,432
+31% +$3.43M ﹤0.01% 2370
2022
Q2 		$10.6M Sell
71,255
-33,600
-32% -$5.13M ﹤0.01% 2630
2022
Q1 		$17.9M Buy
104,855
+20,029
+24% +$3.37M ﹤0.01% 2248
2021
Q4 		$21.9M Buy
84,826
+21,272
+33% +$5.83M ﹤0.01% 2129
2021
Q3 		$17.4M Sell
63,554
-46,769
-42% -$14.9M ﹤0.01% 2299
2021
Q2 		$24.7M Sell
110,323
-164,995
-60% -$31.1M ﹤0.01% 1953
2021
Q1 		$30.1M Buy
275,318
+202,941
+280% +$21.6M ﹤0.01% 1686
2020
Q4 		$5.9M Sell
72,377
-37,906
-34% -$3.72M ﹤0.01% 2981
2020
Q3 		$7.64M Buy
110,283
+93,275
+548% +$6.69M ﹤0.01% 2515
2020
Q2 		$1.14M Buy
17,008
+14,960
+730% +$747K ﹤0.01% 4029
2020
Q1 		$120K Buy
2,048
+1,048
+105% +$40.8K ﹤0.01% 5410
2019
Q4 		$34K Buy
+1,000
New +$22.4K ﹤0.01% 6364

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Bank of America's BNTX Position: Q2 2026 in Review

Bank of America reduced its BioNTech (BNTX) stake by 46% in Q2 2026, selling an estimated $39.2M and leaving 486,205 shares worth $45.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1794.

Bank of America first reported a position in BNTX in Q4 2019 and has held it in 27 quarters since. The position peaked at $80.3M in Q1 2026. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Bank of America held 486,205 shares of BioNTech worth $45.2M as of Q2 2026.
  • Bank of America sold 416,824 BioNTech shares in Q2 2026, an estimated $39.2M.
  • BioNTech made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #1794 holding.
  • Bank of America first reported a position in BioNTech in Q4 2019 and has held it in 27 quarters since.
  • Bank of America's BioNTech position peaked at $80.3M in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.